Cytoprotective doses of erythropoietin or carbamylated erythropoietin have markedly different procoagulant and vasoactive activities

Recombinant human erythropoietin (rhEPO) is receiving increasing attention as a potential therapy for prevention of injury and restoration of function in nonhematopoietic tissues. However, the minimum effective dose required to mimic and augment these normal paracrine functions of erythropoietin (EP...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Coleman, Thomas R., Westenfelder, Christof, Tögel, Florian E., Yang, Ying, Hu, Zhuma, Swenson, LeAnne, Leuvenink, Henri G. D., Ploeg, Rutger J., d’Uscio, Livius V., Katusic, Zvonimir S., Ghezzi, Pietro, Zanetti, Adriana, Kaushansky, Kenneth, Fox, Norma E., Cerami, Anthony, Brines, Michael
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: National Academy of Sciences 2006
Konular:
Biological Sciences
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC1458681/
https://ncbi.nlm.nih.gov/pubmed/16585502
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.0601377103
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller